10.72
price up icon33.67%   2.70
after-market Handel nachbörslich: 10.31 -0.41 -3.82%
loading
Schlusskurs vom Vortag:
$8.02
Offen:
$9.11
24-Stunden-Volumen:
1.78M
Relative Volume:
38.04
Marktkapitalisierung:
$84.59M
Einnahmen:
$2.09M
Nettoeinkommen (Verlust:
$-5.28M
KGV:
-16.00
EPS:
-0.67
Netto-Cashflow:
$-3.64M
1W Leistung:
+39.22%
1M Leistung:
+32.18%
6M Leistung:
+135.48%
1J Leistung:
+82.00%
1-Tages-Spanne:
Value
$9.05
$11.68
1-Wochen-Bereich:
Value
$7.60
$11.68
52-Wochen-Spanne:
Value
$3.7223
$11.78

Nutriband Inc Stock (NTRB) Company Profile

Name
Firmenname
Nutriband Inc
Name
Telefon
407 377-6695
Name
Adresse
121 S. ORANGE AVE., ORLANDO
Name
Mitarbeiter
3
Name
Twitter
Name
Nächster Verdiensttermin
2025-05-02
Name
Neueste SEC-Einreichungen
Name
NTRB's Discussions on Twitter

Vergleichen Sie NTRB mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
NTRB
Nutriband Inc
10.72 84.59M 2.09M -5.28M -3.64M -0.67
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Nutriband Inc Stock (NTRB) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-01-22 Eingeleitet Noble Capital Markets Outperform

Nutriband Inc Aktie (NTRB) Neueste Nachrichten

pulisher
Jun 18, 2025

Nutriband and Kindeva Complete Commercial Manufacturing Process Scale-Up for Aversa?? Fentanyl Abuse Deterrent Fentanyl Patch - MarketScreener

Jun 18, 2025
pulisher
Jun 18, 2025

Nutriband and Kindeva Complete Commercial Manufacturing - GlobeNewswire

Jun 18, 2025
pulisher
Jun 18, 2025

Nutriband and Kindeva Complete Commercial Manufacturing Process - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Nutriband (NTRB) Advances Aversa Fentanyl Manufacturing Process | NTRB Stock News - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Nutriband, Kindeva complete commercial manufacturing process scale-up for Aversa - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

Revolutionary Abuse-Deterrent Fentanyl Patch Completes Manufacturing Scale-up: $200M Market Potential - Stock Titan

Jun 18, 2025
pulisher
Jun 13, 2025

Nutriband Inc. Reports Significant Revenue Growth and Advances in AVERSA Fentanyl Development - citybuzz -

Jun 13, 2025
pulisher
Jun 10, 2025

(NTRB) Proactive Strategies - news.stocktradersdaily.com

Jun 10, 2025
pulisher
Jun 10, 2025

Nutriband (NASDAQ: NTRB) Secures U.S. Patent for Abuse-Deterrent Transdermal Technology - The Globe and Mail

Jun 10, 2025
pulisher
Jun 09, 2025

Nutriband Inc. Secures U.S. Patent for Innovative Abuse-Deterrent Transdermal Technology - citybuzz -

Jun 09, 2025
pulisher
Jun 09, 2025

Nutriband secures US patent for abuse deterrent patch technology By Investing.com - Investing.com South Africa

Jun 09, 2025
pulisher
Jun 09, 2025

Nutriband issued U.S. patent for transdermal abuse deterrent technology - TipRanks

Jun 09, 2025
pulisher
Jun 09, 2025

Nutriband Announces U.S. Patent Issued for Its Transdermal Abuse Deterrent Technology - The Manila Times

Jun 09, 2025
pulisher
Jun 09, 2025

Nutriband secures US patent for abuse deterrent patch technology - Investing.com Australia

Jun 09, 2025
pulisher
Jun 09, 2025

Nutriband Announces U.S. Patent Issued for Its Transdermal Abuse Deterrent Technology | NTRB Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Nutriband (NTRB) Secures Patent for Abuse Deterrent Technology | NTRB Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Nutriband Secures Game-Changing Patent for First-Ever Abuse-Deterrent Fentanyl Patch Technology - Stock Titan

Jun 09, 2025
pulisher
Jun 06, 2025

Nutriband (NASDAQ: NTRB) Advances Abuse-Deterrent Buprenorphine Therapy with AVERSA Technology - Barchart.com

Jun 06, 2025
pulisher
Jun 05, 2025

Nutriband (NASDAQ: NTRB): A Relentless Mission Rooted in Purpose, Innovation, and Shareholder Value - The Globe and Mail

Jun 05, 2025
pulisher
Jun 04, 2025

Nutriband Inc. Pioneers Abuse-Deterrent Technology with AVERSA, Targets $800 Million Market Potential - citybuzz -

Jun 04, 2025
pulisher
Jun 03, 2025

Nutriband Inc. to present at the 2025 Noble Capital Markets Virtual Equity Conference - GlobeNewswire

Jun 03, 2025
pulisher
Jun 03, 2025

Nutriband (NASDAQ: NTRB) to Present at Noble Capital Markets Emerging Growth Virtual Conference - The Globe and Mail

Jun 03, 2025
pulisher
Jun 03, 2025

Nutriband CEO Reveals Growth Strategy: Exclusive Virtual Presentation at Noble Capital Conference - Stock Titan

Jun 03, 2025
pulisher
Jun 03, 2025

Nutriband reports Q1 revenue up 63% y/y at $667K - TipRanks

Jun 03, 2025
pulisher
Jun 02, 2025

Nutriband First Quarter 2026 Earnings: EPS Beats Expectations - Yahoo Finance

Jun 02, 2025
pulisher
Jun 02, 2025

Nutriband (NASDAQ: NTRB) Posts Record Q1 Revenue, Advances AVERSA Fentanyl Development - The Globe and Mail

Jun 02, 2025
pulisher
Jun 02, 2025

Nutriband Inc. Reports Revenue Results for the First Quarter Ended April 30, 2025 - MarketScreener

Jun 02, 2025
pulisher
Jun 02, 2025

Nutriband Inc. Provides Update on the Development of AVERSA Fentanyl - MarketScreener

Jun 02, 2025
pulisher
Jun 02, 2025

Nutriband (NTRB) Expands Kinesiology Tape Production and Advances Drug Delivery Solutions | NTRB Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q1, 2025 up 63% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl - The Manila Times

Jun 02, 2025
pulisher
Jun 02, 2025

Nutriband Inc. Quarterly Report Highlights Record Revenue - GlobeNewswire

Jun 02, 2025
pulisher
Jun 02, 2025

Nutriband Q1 Revenue Surges 63% as AVERSA Fentanyl Development Advances | NTRBW Stock News - Stock Titan

Jun 02, 2025
pulisher
Jun 02, 2025

Nutriband Inc. (NTRB) reports Q1 loss, misses revenue estimates - FXStreet

Jun 02, 2025
pulisher
Jun 01, 2025

Nutriband Inc. (NTRB) Reports Q1 Loss, Misses Revenue Estimates - MSN

Jun 01, 2025
pulisher
May 30, 2025

NutriBand Inc. SEC 10-Q Report - TradingView

May 30, 2025
pulisher
May 29, 2025

(NTRB) Investment Analysis - news.stocktradersdaily.com

May 29, 2025
pulisher
May 27, 2025

Nutriband Addresses Opioid Pain Management Challenges with Innovative Transdermal Solution - citybuzz -

May 27, 2025
pulisher
May 27, 2025

Nutriband (NASDAQ: NTRB) CEO Highlights Transdermal Pain Solution on BioMedWire Podcast - Barchart.com

May 27, 2025
pulisher
May 27, 2025

IBN Announces Latest Episode Of The Biomedwire Podcast Featuring Gareth Sheridan, CEO Of Nutriband Inc. - marketscreener.com

May 27, 2025
pulisher
May 27, 2025

IBN Announces Latest Episode of The BioMedWire Podcast Featuring Gareth Sheridan, CEO of Nutriband Inc. - GlobeNewswire

May 27, 2025
pulisher
May 23, 2025

Nutriband (NASDAQ: NTRB) Charts Path To Commercialization - Barchart.com

May 23, 2025
pulisher
May 23, 2025

Stocks in play: Brookfield Corporation - The Globe and Mail

May 23, 2025
pulisher
May 23, 2025

Nutriband Advances Opioid Pain Patch Technology with Strategic Partnership - citybuzz -

May 23, 2025
pulisher
May 20, 2025

Concern Rises over Market Valutions and Structural Vibrations - The Globe and Mail

May 20, 2025
pulisher
May 18, 2025

(NTRB) On The My Stocks Page - news.stocktradersdaily.com

May 18, 2025
pulisher
May 16, 2025

Nutriband (NASDAQ: NTRB) Strengthens Pharma Footprint Through Key Alliances - Barchart.com

May 16, 2025
pulisher
May 15, 2025

Nutriband Expands Market Presence Through Strategic Health Industry Partnerships - citybuzz -

May 15, 2025
pulisher
May 15, 2025

Why Isn't Palantir's Stock Taking Off After Another Strong Quarter? - The Globe and Mail

May 15, 2025
pulisher
May 14, 2025

Nutriband (NASDAQ: NTRB) Pioneers Innovative Approach to Opioid Crisis with Game-Changing Transdermal Patch - Barchart.com

May 14, 2025
pulisher
May 09, 2025

Nutriband Develops Innovative Abuse-Deterrent Fentanyl Patch Amid Opioid Crisis Regulatory Changes - citybuzz -

May 09, 2025
pulisher
May 09, 2025

Nutriband (NASDAQ: NTRB) Innovating Abuse-Deterrent Drug Delivery in a Shifting Opioid Landscape - Barchart.com

May 09, 2025

Finanzdaten der Nutriband Inc-Aktie (NTRB)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):